243 filings
Page 6 of 13
8-K
2wvr2l8uin 73
12 Apr 23
Entry into a Material Definitive Agreement
5:00pm
8-K
auu24b4 6p93o
11 Apr 23
Abstract Evaluating Allarity’s DRP® Companion Diagnostic for Cisplatin Accepted at 2023 ASCO Annual Meeting
9:19am
8-K
j3643fspmelsqwo
28 Mar 23
Allarity Therapeutics Provides Updates for IXEMPRA and Stenoparib Phase 2 Monotherapy Clinical Studies
5:15pm
8-K
lqrg7sr3 0jhd30mz3vm
24 Mar 23
Allarity Therapeutics Announces Reverse Stock Split of Common Stock
6:08am
8-K
zrjmu69c hu6lo
20 Mar 23
Amendments to Articles of Incorporation or Bylaws
5:14pm
8-K
y43d5lt6jd5zgq8bcj6
20 Mar 23
Regulation FD Disclosure
6:05am
8-K
bj000aw
9 Mar 23
Regulation FD Disclosure
5:10pm
D
l0bsknh9
28 Feb 23
$1.20 mm in equity, sold $1.20 mm, 1 investor
6:54pm
8-K
mi3itd7xugg0tkj g7
28 Feb 23
Entry into a Material Definitive Agreement
5:25pm
8-K
3jqh8pf 5e8rgx
10 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
vuh1skvgv2lq kmmf
6 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:33am
DEFA14A
7t9vfzrnhs
24 Jan 23
Additional proxy soliciting materials
6:02am
424B3
opz 4btrbb
23 Jan 23
Prospectus supplement
5:11pm
8-K
adgnb8g9qq5ok6r7q6uu
23 Jan 23
Entry into a Material Definitive Agreement
6:30am